Today's Daily Dose brings you news about another headstone in the graveyard of NASH drugs, ADC Therapeutics' near-term catalysts, Gilead's Filgotinib being turned down by the FDA, Sorrento terminating its CFO, Supernus' regulatory catalyst for November, and Vanda's progress in COVID-19 treatment Tradipitant.
from RTT - Biotech https://ift.tt/2Yc3KDm
via IFTTT
No comments:
Post a Comment